Injective CEO: US INJ spot ETF expected to launch before 2027

October 5 — Injective co-founder and CEO Eric Chen said he expects a U.S. ETF tied to the Layer 1 network's native token INJ to launch before 2027.

In an interview during Korea Blockchain Week 2026, Chen said, "I can't comment on the specific timing, but I think 2027 is a bit too late. In fact, progress is moving much faster than I expected, so we'll see."

According to the U.S. Securities and Exchange Commission (SEC) website, there are currently two ETF applications related to INJ, namely the 21Shares Injective ETF and the Canary Staked INJ ETF. Both issuers initially filed applications in 2025 and submitted amended S-1 registration statements in September of this year, indicating that the relevant application process is making progress.